Regenerative medicine is a modern, non-operative procedure utilizing the body’s natural ability to address many issues
HTT may involve either structural tissues or cells/nonstructural tissues, depending on the characteristics of the tissue in the donor. HTTs may only be used in the recipient patient for the same basic function as the cells/tissue functioned in the donor (homologous use). Some types of HTT may be used as a structural scaffold that supports the cellular activity required for reconstruction of the patient’s tissue.
Bone-on-Bone Joint Pain & Old, Nagging Injuries
Disclaimer: None of the statements on this page are intended to make any claims about HTT, but instead describe many of the basic functions of native human tissue. Per FDA Guidance, it is not necessary for the HCT/P in the recipient to perform all of the basic functions it performed in the donor in order to meet the definition of homologous use. Human Tissue Therapy, as we use that term on this website, are minimally manipulated cells and tissues intended for homologous use only. None of the mentioned statements have been evaluated by the FDA. As defined in 21 CFR 1271.3(c), homologous use means the repair, reconstruction, replacement, or supplementation of a recipient’s cells or tissues with an HTT/P that performs the same basic function or functions in the recipient as in the donor. Human Tissue Therapies are not intended to diagnose, treat, cure or prevent any disease including COVID-19.